BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 59 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $61,105 | +57.7% | 12,100 | -41.0% | 0.00% | – |
| Q1 2023 | $38,745 | -47.8% | 20,500 | -50.2% | 0.00% | – |
| Q4 2022 | $74,160 | -32.0% | 41,200 | -36.1% | 0.00% | – |
| Q3 2022 | $109,000 | -51.1% | 64,500 | -28.8% | 0.00% | -100.0% |
| Q2 2022 | $223,000 | -27.1% | 90,600 | -18.0% | 0.00% | 0.0% |
| Q1 2022 | $306,000 | -48.3% | 110,500 | +352.9% | 0.00% | 0.0% |
| Q1 2021 | $592,000 | -27.5% | 24,400 | -4.3% | 0.00% | -50.0% |
| Q4 2020 | $817,000 | +45.4% | 25,500 | +37.1% | 0.00% | +100.0% |
| Q3 2020 | $562,000 | -28.3% | 18,600 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $784,000 | +69.0% | 18,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $464,000 | – | 18,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |